K. Peony Yu
2017
In 2017, K. Peony Yu earned a total compensation of $3.1M as Chief Medical Officer at FibroGen, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $393,750 |
|---|---|
| Option Awards | $1,154,818 |
| Salary | $525,000 |
| Stock Awards | $1,045,870 |
| Other | $18,331 |
| Total | $3,137,769 |
Yu received $1.2M in option awards, accounting for 37% of the total pay in 2017.
Yu also received $393.8K in non-equity incentive plan, $525K in salary, $1M in stock awards and $18.3K in other compensation.
Rankings
In 2017, K. Peony Yu's compensation ranked 3,446th out of 14,666 executives tracked by ExecPay. In other words, Yu earned more than 76.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,446 out of 14,666 | 77th |
Division Manufacturing | 1,183 out of 5,772 | 80th |
Major group Chemicals And Allied Products | 328 out of 2,075 | 84th |
Industry group Drugs | 250 out of 1,731 | 86th |
Industry Pharmaceutical Preparations | 199 out of 1,333 | 85th |
Source: SEC filing on April 24, 2018.
Yu's colleagues
We found two more compensation records of executives who worked with K. Peony Yu at FibroGen in 2017.